5600EGP
- Active ingredient
- ranibizumab
- Strength
- 0.5mg/5ml
- Form
- vial
- Manufacturer
- novartis
- Route
- injection
Uses
Indicated for neovascular age-related macular degeneration, macular edema following retinal vein occlusion, and myopic choroidal neovascularization.
Do not use if
Ocular or periocular infections and hypersensitivity to ranibizumab or formulation components.
Side effects
May cause eye pain, increased intraocular pressure, conjunctival hemorrhage, endophthalmitis, and retinal detachment.
Warnings
Monitor for endophthalmitis, retinal detachment, elevated intraocular pressure, and thromboembolic events.
How it works
VEGF-A inhibitor that reduces abnormal blood vessel growth and vascular leakage in the eye.
Storage
Store refrigerated at 2–8°C. Do not freeze. Protect from light.